A milestone in the treatment of cystic fibrosis
The latest episode of the Mayo Clinic Q&A podcast, features a milestone in the treatment of cystic fibrosis (CF). Tim Myer has lived with cystic fibrosis his whole life. He was awaiting a lung transplant, when a new medication approved by the Food and Drug Administration changed everything. "There are about 30,000 patients in the U.S. with cystic fibrosis. This drug will expand treatment to 27,000, or 90% of all patients with CF in the U.S.," says Dr. Mark Wylam, a Mayo Clinic pulmonologist, and Myer's physician. Myer and Dr. Wylam share the story on this week's Mayo Clinic Q&A podcast.
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The latest episode of the Mayo Clinic Q&A podcast, features a milestone in the treatment of cystic fibrosis (CF).
Tim Myer has lived with cystic fibrosis his whole life. He was awaiting a lung transplant, when a new medication approved by the Food and Drug Administration changed everything.
"There are about 30,000 patients in the U.S. with cystic fibrosis. This drug will expand treatment to 27,000, or 90% of all patients with CF in the U.S.," says Dr. Mark Wylam, a Mayo Clinic pulmonologist, and Myer's physician.
Myer and Dr. Wylam share the story on this week's Mayo Clinic Q&A podcast.
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy